| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
| mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
0.16 |
0.0007 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.001 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |